Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q34183257

about

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience Current State of Vascular Resections in Pancreatic Cancer Surgery Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer.Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection.Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer.Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific α/β-Values for Patients with Non-Resectable Pancreatic Cancer.Vascular Resection in Pancreatic Cancer.Response evaluation following neoadjuvant treatment of pancreatic cancer patients CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer.Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression.Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines.Advanced-stage pancreatic cancer: therapy options.TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancer.Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer.Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells.Changes in Gross Tumor Volume and Organ Motion Analysis During Neoadjuvant Radiochemotherapy in Patients With Locally Advanced Pancreatic Cancer Using an In-House Analysis System.Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer.Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.[Resection plus adjuvant chemotherapy improves survival in advanced pancreatic adenocarcinoma].[Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations.[Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer]

P2860

Q24622390-34EECCC7-E4FD-445F-9073-BDE20C471FE3 Q26861676-2FB81A99-2474-45D6-A686-17BA75A15177 Q33712975-6349AA25-3B6A-4FED-9D2D-B5C3A19649A3 Q33748302-F1089D5F-727A-4EA9-BC99-99C0F8EDC49B Q34570002-B45CFF77-A2DA-41EA-BB13-A9582FAF94F8 Q34986932-2C025A6A-C9D1-4343-8DD4-531CF0461BBC Q35504794-CAE3176E-96BB-4567-9A3A-55DBB0296A8A Q35847721-F4F4C2E8-61B0-4870-81F5-29E7EBE1C133 Q36162620-21DD5E9D-6BA0-4BAB-9C2D-7D6F36C61CE8 Q36400053-A4753782-AE7B-4B40-A4C8-4692D6A79506 Q36693226-336514C2-72DA-4C2E-9C84-CD284F6CC45D Q37033444-674C3288-9286-47DD-8288-3A83EBF0B375 Q37277436-84D246E3-4CC5-4609-BE54-06033CFFC201 Q37628435-BA3CD783-BDEE-4259-B476-0489C0035744 Q37694481-37642C10-8178-4A32-B85F-5B008089436B Q38102914-0073DFCD-A7C8-462A-BCD7-D9BBAEBD3713 Q38204280-91D9F902-D7DF-4BBA-8AC0-86CD92BFF2C3 Q38413842-08215123-F3B4-44EC-A547-3E83ABD8D481 Q39125807-AA2BFE55-4F0D-4B4C-8E8D-6B259D0A0B42 Q39177574-C5BC6F4F-BC94-498C-8365-2F47F1527D02 Q39375998-60545748-4C3D-4B2D-A923-D3FDD1EEBA30 Q39376002-6C39B07B-BE78-40B1-B011-33019DAAE7DB Q40994485-837DF6B9-7A83-4B4D-93BA-A5E235F16921 Q41138758-F805A0CF-E4F2-44D9-BED5-8A66B2119B21 Q42155783-BA44E477-7F7C-4AFA-8C40-647A4DD0D472 Q42318810-791CF59E-53C5-4478-B168-D52475CA2248 Q42374126-7B862DFF-153F-46A8-BAFD-F12416DB45BF Q44145390-0666A26C-9E52-4AFF-BAB8-5D1DF5348B93 Q44650345-4A13E84C-6393-4CAF-ACFD-A5D069145C07 Q47161355-0DA44405-3DA7-4362-A928-EA9F621174EA Q50221174-CBBABF6D-2777-4DED-AE5C-D05E3720CF12 Q56743652-B0A17544-4C90-44CB-AF0F-5D8562E737BB

P2860

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q34183257

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@ast

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@en

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@nl

type

label

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@ast

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@en

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@nl

prefLabel

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@ast

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@en

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@nl

P1433

Q34183257-E883C88F-4676-4E29-AE8E-742F3D8BE273

P1476

Q34183257-D5C6DA82-E09E-418C-8498-314692D7C126

P2093

Q34183257-02A9D2CF-A065-4CA1-91F6-0694667478BC

Q34183257-0777013A-6C44-4D53-B964-5BFDA309E1D0

Q34183257-0DDCEDDA-3B17-42BF-BEEA-2B748857B8A7

Q34183257-4E86DD99-0754-4C67-8FEC-B07F5FABD022

Q34183257-9447AF2A-34D7-4CFE-8F86-5403C2836C0E

Q34183257-B2E99C38-F36C-43D2-8DDF-B6CEA59B8445

Q34183257-C12778F0-1A82-450D-93B4-F11142CFC6EC

Q34183257-C952E83B-6335-4D35-A4D9-3769AAB084CD

Q34183257-ED44D712-40DE-41B8-9760-E30354B8F0AF

Q34183257-F2A84FA7-4C00-4BE8-84C6-427E367FA65D

P2860

Q34183257-0E61F40D-26A4-4BD2-BAAE-22671681FC3C

Q34183257-10920D0C-69AE-4A0B-BE5B-B8893BA2E419

Q34183257-15DE83D2-50E2-40E7-BA85-11C8B7DA9AE0

Q34183257-1EF952A7-67A0-48AD-AB33-C0B76B38AAC4

Q34183257-26DE38AF-592E-472A-A014-29A1F90EFCBC

Q34183257-2A7C5624-0BF3-4430-A9CF-6A73D7BE2EEF

Q34183257-2D88DF61-851B-42E0-ABD2-CA661344F487

Q34183257-3F2C4AE5-8CE8-4559-ABE0-743643C7A95A

Q34183257-4818D422-6B1A-4654-A7E1-ED4DC6138C5A

Q34183257-52FB931C-8126-4552-B188-12546FA5EB4C

P2888

Q34183257-DC724B49-CFEC-4038-856B-A7B3F9310D19

P304

Q34183257-00DBFE7A-CD6F-4EB0-87DC-C479A530E8A3

P31

Q34183257-E20BEEEA-80E6-494F-9CE7-8FC665EC7609

P356

Q34183257-A9238640-BD2E-42DA-B76C-00C24FF18968

P478

Q34183257-F0A1CB04-9C0A-4031-875E-6B9C5FA05FD8

P50

Q34183257-3006CF53-AA01-4914-9F94-20EA2F0CB673

Q34183257-761232A4-292A-4EAC-AA43-3D2A61733251

Q34183257-E5568FC1-961D-44BA-8A88-DD7F5B2BBD9A

P577

Q34183257-4D426A06-F722-4524-991B-B5D58FB35096

P5875

Q34183257-8261A967-BFB0-4B95-95F2-7550F6600900

P6179

Q34183257-D1B670B2-975C-48FD-8AD5-1B7C9EDC76AD

P698

Q34183257-799CA43F-CC14-478D-A264-D25A4DB4A3D2

P921

Q34183257-0D104F01-0B05-49DF-BB05-82F0A2261EC8

P932

Q34183257-FDB6585E-0357-48E9-B472-95516BC549CB

P356

P1433

Radiation Oncology

P1476

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

@en

P2093

Amir Abdollahi

http://www.w3.org/2001/XMLSchema#string

Daniel Habermehl

http://www.w3.org/2001/XMLSchema#string

Frank Bergmann

http://www.w3.org/2001/XMLSchema#string

Holger Hof

http://www.w3.org/2001/XMLSchema#string

Jens Werner

http://www.w3.org/2001/XMLSchema#string

Kerstin Kessel

http://www.w3.org/2001/XMLSchema#string

Peter Schirmacher

http://www.w3.org/2001/XMLSchema#string

Stefan Rieken

http://www.w3.org/2001/XMLSchema#string

Stephanie E Combs

http://www.w3.org/2001/XMLSchema#string

Thomas Welzel

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Pancreatic cancer

Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.

The role of radiotherapy in multimodal treatment of pancreatic carcinoma

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

One thousand consecutive pancreaticoduodenectomies.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.

P2888

P304

28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-7-28

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Markus Büchler

P577

2012-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221883993

http://www.w3.org/2001/XMLSchema#string

P6179

1025997931

http://www.w3.org/2001/XMLSchema#string

P698

22385572

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3338091

http://www.w3.org/2001/XMLSchema#string